Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking

References

• Wang , JC . 2002 . Cellular roles of DNA topoisomerases: A molecular perspective . Nat. Rev. Mol. Cell. Biol. , 3 : 430 – 440 .
   PubMed Web of Science ®Google Scholar
• Gellert , M . 1981 . DNA topoisomerases . Annu. Rev. Biochem. , 50 : 879 – 910 .
   PubMed Web of Science ®Google Scholar
• Wang , JC . 1985 . DNA topoisomerases . Annu. Rev. Biochem. , 54 : 665 – 697 .
   PubMed Web of Science ®Google Scholar
• Vosberg , HP . 1985 . DNA topoisomerases: Enzymes that control DNA conformation . Curr. Top. Microbiol. Immunol. , 114 : 19 – 102 .
   PubMed Web of Science ®Google Scholar
• N.R. Cozzarelli and J.C. Wang, eds., DNA Topology and its Biological Effects, Cold Spring Harbor Laboratory Press, Plainview, NY, 1990
   Google Scholar
• Wang , JC . 1996 . DNA topoisomerases . Annu. Rev. Biochem. , 65 : 635 – 692 .
   PubMed Web of Science ®Google Scholar
• Champoux , JJ . 2001 . DNA topoisomerases: Structure, function, and mechanism . Annu. Rev. Biochem. , 70 : 369 – 413 .
   PubMed Web of Science ®Google Scholar
• Beck , LS , DeGuzman , L , Lee , WP , Xu , Y , Siegel , MW and Amento , EP . 1993 . One systemic administration of transforming growth factor-β1 Reverses age- or glucocorticoid-impaired wound healing . J. Clin. Invest. , 92 : 2841 – 2849 .
   PubMed Web of Science ®Google Scholar
• Osheroff , N . 1989 . Effect of antineoplastic agents on the DNA cleavage/religation equlibrium of eukaryotic topoisomerase II: Inhibition of DNA religation by etoposide . Biochemistry , 28 : 6157 – 6160 .
   PubMed Web of Science ®Google Scholar
• Chow , KC , Macdonald , TL and Ross , WE . 1988 . DNA binding by epipodophyllotoxins and A'-acyl anthracyclines: Implications for mechanism of to poisomerase Minhibition . Mol. Pharmacol. , 34 : 467 – 473 .
   PubMed Web of Science ®Google Scholar
• Aisner , J , Belani , CP and Doyle , LA . 1994 . Etoposide: Current status and future perspectives in the management of malignant neoplasms . Cancer Chemoter. Pharmacol. , 34 : 118 – 126 .
   Web of Science ®Google Scholar
• Alper , S , Temiz-Arpaci , O , Aki-Sener , E and Yalcin , I . 2003 . Some bi- and ter- benzimidazole derivatives as topoisomerase I inhibitors . Il Farmaco , 58 : 497 – 507 .
   PubMedGoogle Scholar
• Tolner , B , Hartley , JA and Hochhauser , D . 2001 . Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs . Mol. Pharmacol. , 59 : 699 – 706 .
   PubMed Web of Science ®Google Scholar
• Sun , Q , Gatto , B , Yu , C , Liu , A , Liu , LF and LaVoie , EJ . 1995 . Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors . J. Med. Chem. , 38 : 3638 – 3644 .
   PubMed Web of Science ®Google Scholar
• Finlay , GJ and Baguley , BC . 1990 . Potentiation by phenylbisbenzimidazoles of cytotoxicity of anti-cancer drugs directed against topoisomerase II . Eur. J. Cancer , 26 : 586 – 589 .
   PubMed Web of Science ®Google Scholar
• Rowe , TC , Chen , GL , Hsiang , YH and Liu , F . 1986 . DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II . Cancer Res. , 46 : 2021 – 2026 .
   PubMed Web of Science ®Google Scholar
• Peel , MR , Milstead , MW , Sternbach , DD , Besterman , M , Leitner , P and Morton , B . 1995 . Novel A-ring modified camptothecins as topoisomerase I inhibitors . Bioorg. Med. Chem. Lett. , 5 : 2129 – 2132 .
   Web of Science ®Google Scholar
• Shi , D-F , Bradshaw , TD , Wrigley , S , McCall , CJ , Lelieveld , P , Fichtner , I and Stevens , MF . 1996 . Antitumor benzothiazoles. 3.1 Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo . J. Med. Chem. , 39 : 3375 – 3384 .
   PubMed Web of Science ®Google Scholar
• Choi , S-J , Park , HJ , Lee , SK , Kim , SW , Han , G and Choo , H-YP . 2006 . Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity . Bioorg. Med. Chem. , 14 : 1229 – 1235 .
   PubMed Web of Science ®Google Scholar
• Pınar , A , Yurdakul , P , Yıldız-Ören , İ , Temiz-Arpacı , Ö , Acan , NL , Akı-Şener , E and Yalçın , İ . 2004 . Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors . Biochem. Biophys. Res. Comm. , 317 : 670 – 674 .
   PubMed Web of Science ®Google Scholar
• Temiz-Arpaci , O , Tekiner-Gulbas , B , Yildiz , I , Aki-Sener , E and Yalcin , I . 2005 . 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method . Bioorg. Med. Chem. , 13 : 6354 – 6359 .
   PubMed Web of Science ®Google Scholar
• Tekiner-Gulbas , B , Temiz-Arpaci , O , Yildiz , I , Aki-Sener , E and Yalcin , I . 2006 . 3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA . SAR QSAR Environ. Res. , 17 : 121 – 132 .
   PubMed Web of Science ®Google Scholar
• Schoeffler , AJ and Berger , JM . 2008 . DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology . Quart. Rev. Biophys. , 41 : 41 – 101 .
   PubMed Web of Science ®Google Scholar
• Dong , KC and Berger , JM . 2007 . Structural basis for gate-DNA recognition and bending by type IIA topoisomerases . Nature , 450 : 1201 – 1205 .
   PubMed Web of Science ®Google Scholar
• Wu , G , Robertson , DH , Brooks , CL III and Vieth , M . 2003 . Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm . J. Comp. Chem. , 24 : 1549
   PubMed Web of Science ®Google Scholar
• Brooks , BR , Bruccoleri , RE , Olafson , BD , States , DJ , Swaminathan , S and Karplus , M . 1983 . CHARMM: A program for macromolecular energy minimization and dynamics calculations . J. Comp. Chem. , 4 : 187 – 217 .
   Web of Science ®Google Scholar
• Maanen , JM , van Retel , J , Vries , J and de Pinedo , HM . 1988 . Mechanism of action of antitumor drug etoposide: A review . J. Natl. Cancer Inst. , 80 : 1526 – 1533 .
   PubMed Web of Science ®Google Scholar
• Friesner , RA , Banks , JL , Murphy , RB , Halgren , TA , Klicic , JJ , Mainz , DT , Repasky , MP , Knoll , EH , Shaw , DE , Shelley , M , Perry , JK , Francis , P and Shenkin , PS . 2004 . Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy . J. Med. Chem. , 47 : 1739 – 1749 .
   PubMed Web of Science ®Google Scholar
• Burden , DA and Osheroff , N . 1998 . Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme . Biochim. Biophys. Acta , 1400 : 139 – 154 .
   PubMed Web of Science ®Google Scholar
• Muller , SO , Eckert , I , Lutz , WK and Stopper , H . 1996 . Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? . Mutat. Res. , 371 : 165
   PubMed Web of Science ®Google Scholar